Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive
Researchers at the University of Helsinki, Finland, have defined a cancer invasion machinery, which is…
Bacon: how you cook it could partially lower cancer risk
Richard Hoffman, University of Hertfordshire Bacon is a much-loved, comforting breakfast item – during the…
Scientists are a step closer to developing ‘smart’ stem cells – and they’re made from human fat
These new, adaptive stem cells can lie dormant until needed, a new animal study using…
Inflammation a key to targeting pregnancy-associated breast cancer
- Long-term results from MINDACT trial confirm importance of gene expression signature in choosing breast cancer patients who can be spared chemotherapy
- Configuring infrared spectroscopy tools to better detect breast cancer
- Breast cancer survivors’ fear of cancer returning linked to genomic testing, psychological factors
Could taking vitamins in huge doses produce a health miracle after all?
Peter McCaffery, University of Aberdeen For decades, some people have embraced the idea that there might be major health benefits…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.